HTD4010

HighTide Biopharma Pty Ltd · Phase 1 active Small molecule

At a glance

Generic name	HTD4010
Also known as	analog of INGAP peptide
Sponsor	HighTide Biopharma Pty Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of HTD4010 in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HTD4010 CI brief — competitive landscape report
HTD4010 updates RSS · CI watch RSS
HighTide Biopharma Pty Ltd portfolio CI